DexCom Inc (BSP:D1EX34)
R$ 9.65 0 (0%) Market Cap: 188.46 Bil Enterprise Value: 189.05 Bil PE Ratio: 47.26 PB Ratio: 15.58 GF Score: 74/100

DexCom Inc at Wells Fargo Virtual Healthcare Conference Transcript

Sep 10, 2020 / 03:20PM GMT
Operator

Welcome to the Wells Fargo Health Care Conference. (Operator Instructions) Also, please be advised that today's conference is being recorded. Thank you.

Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

Good morning, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo, and it's my pleasure to host this session with DexCom. With us, we have Steve Pacelli, Executive Vice President of Strategy and Corporate Development; and Jereme Sylvain, Senior Vice President of Finance and the Chief Accounting Officer. In terms of the format, it's going to be Q&A. DexCom has been kind enough to give us a 1-hour slot. So hopefully, we can cover a lot of ground here. If people want to ask questions, I'm going to ask you just try to email me. So if I'm looking to my left, you'll know I'm just scanning my e-mail to try to get questions from people on the line. We're also going to try to do one polling question, which is -- has actually worked well so far. And so with that, Steve, and Jereme,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot